-
121
A phase I, randomized, placebo‐controlled trial to evaluate the pharmacokinetics, safety, and tolerability of nirsevimab in healthy Chinese adults
Published 2025-01-01“…Abstract Respiratory syncytial virus (RSV) is the leading cause of lower respiratory tract infection (LRTI) in infants worldwide. Nirsevimab, an extended half‐life monoclonal antibody against RSV, is approved in China for the prevention of RSV lower respiratory tract disease in infants; however, global nirsevimab trials did not enroll Chinese infants. …”
Get full text
Article -
122
An Integrated Approach for Conducting long-term PM2.5 Exposure and Health Impact Assessments for Residents of a City-scale
Published 2024-01-01“…By reference to the results obtained from MMS9yr, using AQMS9yr and h_LUR9yr would respectively lead to the underestimation of the attributed fraction (AFs) ~21%–36% and 18%–26% for the 5 disease burdens, including ischemic heart disease, stroke, chronic obstructive pulmonary disease, lung cancer, and lower respiratory tract infection. The above results clearly indicate the importance of using the integrating approach on conducting EA and HIA.…”
Get full text
Article -
123
Efficacy of yeast beta-glucan 1,3/1,6 supplementation on respiratory infection, fatigue, immune markers and gut health among moderate stress adults in Klang Valley of Malaysia: pro...
Published 2025-01-01“…Given the global prevalence and impact of upper respiratory tract infections (URTIs) on productivity and healthcare costs, YBG has shown promise as a potential therapeutic and preventive strategy for recurrent respiratory tract infections. …”
Get full text
Article -
124
Can primary care research be conducted more efficiently using routinely reported practice-level data: a cluster randomised controlled trial conducted in England?
Published 2022-07-01“…We investigated barriers and facilitators to running a more efficient design.Design An RCT aiming to reduce antibiotic prescribing among children presenting with acute cough and a respiratory tract infection (RTI) with a clinician-focused intervention, embedded at the practice level. …”
Get full text
Article -
125
Long-term safety and sustained efficacy of bimekizumab in patients with ankylosing spondylitis (radiographic axial spondyloarthritis): 5-year results from BE AGILE (phase 2b) and i...
Published 2025-01-01“…Safety (exposure-adjusted incidence rates/100 patient-years (EAIRs)) and efficacy outcomes (binary: non-responder imputation (NRI) and observed case (OC); continuous: multiple imputation (MI)) are presented through 256 weeks.Results From Weeks 0–256, 289/303 (95.4%) patients had ≥1 treatment-emergent adverse event (TEAE); most frequent were nasopharyngitis (21.8%) and upper respiratory tract infection (14.5%). The EAIR of fungal infections was 7.4 (Candida infections: 2.6; oral candidiasis: 2.2); none systemic. …”
Get full text
Article -
126
Bronchiolitis Severity Affects Blood Count and Inflammatory Marker Levels: A Real-Life Experience
Published 2025-01-01“…Background: Bronchiolitis is the most common cause of lower respiratory tract infection (LRTI) in the first year of life. …”
Get full text
Article -
127
Safe, effective and cost-effective oxygen saturation targets for children and adolescents with respiratory distress: protocol for a randomised controlled trial (OxyKids study)
Published 2024-12-01“…A total of 560 children aged 6 weeks to 12 years admitted with a diagnosis of bronchiolitis, viral wheeze or lower respiratory tract infection will be recruited and equally randomised into an intervention or usual care arm. …”
Get full text
Article -
128
Belimumab versus telitacicept in sequential treatment after rituximab for refractory lupus nephritis: a real-world multicentre study
Published 2025-01-01“…Major adverse effects included immunoglobulin deficiency, respiratory tract infection and urinary tract infection. No death occurred.Conclusions The sequential treatment of belimumab or telitacicept following RTX may represent a promising therapeutic approach in the management of refractory lupus nephritis. …”
Get full text
Article -
129
Perbandingan Efektivitas Daya Hambat Kotrimoksazol Generik dan Paten terhadap Pertumbuhan Bakteri Escherichia coli sebagai Penyebab Infeksi Saluran Kemih secara In Vitro
Published 2015-01-01“…<br />Kata kunci: Escherichia coli, infeksi saluran kemih, sensitivitas, antibiotika, generik, paten</p><p>Abstract<br />Urinary tract infection is one of the infections that are often found after a respiratory tract infection. The major cause of urinary tract infections is Escherichia coli. …”
Get full text
Article -
130
Early Postoperative Safety of Total Hip Arthroplasty in Systemic Lupus Erythematosus Patients
Published 2025-01-01“…Within 30 days postoperatively, 18 cases (6.67%) experienced major complications, including 2 cases (0.74%) of upper respiratory tract infection, 2 cases (0.74%) of pulmonary infection, 3 cases (1.11%) of urinary tract infection, 2 cases (0.74%) of other systemic infection, 5 cases (1.85%) of poor wound healing, 1 case (0.37%) of wound infection, 1 case (0.37%) of gastrointestinal complications, 1 cases (0.37%) of shock, and 1 case (0.37%) of SLE flare-up. …”
Get full text
Article -
131
Recommendation for the use of respiratory syncytial virus vaccines
Published 2025-02-01“…RSV is also a significant viral pathogen for adults with respiratory tract infection.Vaccines targeting the pre-fusion protein of RSV, including recombinant and mRNA vaccines, are now available. …”
Get full text
Article -
132
A randomized, double-blind, Phase 1, single- and multiple-dose placebo-controlled study of the safety and pharmacokinetics of IN-006, an inhaled antibody treatment for COVID-19 in...
Published 2025-03-01“…Summary: Background: Although COVID-19 is predominantly a respiratory tract infection, current antibody treatments are administered by systemic dosing. …”
Get full text
Article -
133
Relevance of superoxide dismutase type 1 to lipoid pneumonia: the first retrospective case-control study
Published 2025-01-01“…LP is difficult to differentiate from other similar diseases without pathological evidence, such as upper respiratory tract infection (URTI), pneumonia, cryptogenic organizing pneumonia (COP), pulmonary alveolar proteinosis (PAP), lung mucinous adenocarcinoma and pulmonary edema. …”
Get full text
Article -
134
The Appearance of Antiphage Antibodies in Sera of Patients Treated with Phages
Published 2025-01-01“…<b>Background</b>: Bacteriophages are neutralized by the sera of patients undergoing phage therapy (PT), particularly during local or concomitant local and oral phage administration in bone infections, soft tissue infections, or upper respiratory tract infections. <b>Methods:</b> The antiphage activity of the sera (AAS) level of 27 patients with bacterial infections such as bone infections, soft tissue infections, or upper respiratory tract infections undergoing PT was performed using the plate phage neutralization test. …”
Get full text
Article -
135
Nutrient conditions affect antimicrobial pharmacodynamics in Pseudomonas aeruginosa
Published 2025-01-01“…ABSTRACT The infectious microenvironment in chronic respiratory tract infections is characterized by substantial variability in nutrient conditions, which may impact colonization and treatment response of pathogens. …”
Get full text
Article -
136
Phenotypes, Risk Factors, and Mechanisms of Adult-Onset Asthma
Published 2015-01-01“…Genetic factors, atopy, and early respiratory tract infections are well-recognized factors predisposing to childhood-onset asthma. …”
Get full text
Article -
137
Remarkably Few Sputum Cultures from People with Parkinson’s Disease during Hospital In-Patient Admission
Published 2015-01-01“…Although respiratory tract infections can be a common complication in people with Parkinson’s disease (PD), there is little published data on the nature of such infections in this patient group. …”
Get full text
Article -
138
Isolated absent pulmonary valve with intact ventricular septum in a young child: A rare case report
Published 2024-12-01“…This report presents a case of such rarity involving a young child with recurrent lower respiratory tract infections.…”
Get full text
Article -
139
Evaluation of Clinical and Immunological Characteristics of Children with Common Variable Immunodeficiency
Published 2018-01-01“…Most patients presented with recurrent infections, including upper respiratory tract infections (n=8), lower respiratory tract infections (n=9), and gastroenteritis (n=5). …”
Get full text
Article -
140
A Case of Prolonged Cholestatic Hepatitis Induced by Azithromycin in a Young Woman
Published 2011-01-01“…Azithromycin, a semisynthetic macrolides, is frequently prescribed for the treatment of middle ear and upper respiratory tract infections, bronchitis, and community-acquired pneumonia. …”
Get full text
Article